Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study

被引：0
|
作者：
Kazuaki Enya
Ben T. Saji
Takuya Kato
Hiroyuki Okamoto
Emiko Koumura
机构：
[1] Takeda Pharmaceutical Co. Ltd,Japan Development Center
[2] Toho University Omori Medical Center,First Department of Pediatrics
[3] Takeda Pharmaceutical Co. Ltd,Formerly Japan Development Center
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Angiotensin II receptor blocker; Azilsartan; Cardiology; Hypertension; Pediatric; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1181 / 1190
页数：9
相关论文
共 50 条
  • [1] Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study
    Enya, Kazuaki
    Saji, Ben T.
    Kato, Takuya
    Okamoto, Hiroyuki
    Koumura, Emiko
    ADVANCES IN THERAPY, 2018, 35 (08) : 1181 - 1190
  • [2] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [3] Pharmacokinetics of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis: Results From a Randomized, Multicenter, Open-Label Phase 3 Study
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Damaraju, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Griffiths, Anne M.
    Ford, Joyce A.
    Zhou, Honghui
    Guzzo, Cynthia A.
    Davis, Hugh M.
    Hyams, Jeffrey S.
    GASTROENTEROLOGY, 2012, 142 (05) : S375 - S375
  • [4] Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open-label, multiple-dose study
    Hershey, Andrew D.
    Lima, Gabriel Paiva da Silva
    Pannacciulli, Nicola
    Mackowski, Mia
    Koukakis, Reija
    McVige, Jennifer Williams
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):
  • [5] Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study
    Kim, Seokuee
    Lee, Jongtae
    Shin, Donghoon
    Lim, Kyoung Soo
    Kim, Yon Su
    Jang, In-Jin
    Yu, Kyung-Sang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1723 - 1731
  • [6] Effect of renal impairment on the pharmacokinetics of prucalopride: a single-dose open-label Phase I study
    Smith, William B.
    Mannaert, Erik
    Verhaeghe, Tom
    Kerstens, Rene
    Vandeplassche, Lieve
    Van de Velde, Vera
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 407 - 415
  • [7] Safety and Pharmacokinetics of IGSC 20% in Subjects with Primary Immunodeficiency in an Open-label, Multicenter, Phase 3 Study
    Sleasman, John
    Darter, Amy
    Lumry, William
    Hussain, Iftikhar
    Wedner, H. James
    Harris, James, III
    Courtney, Kecia
    Mondou, Elsa
    Lin, Jiang
    Stein, Mark R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S48 - S49
  • [8] Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open-label study
    Hide, Michihiro
    Wang, Yi
    Dote, Nobuhito
    Miyakawa, Kou
    Sugiura, Kenkichi
    Ishida, Kazuyuki
    JOURNAL OF DERMATOLOGY, 2023, 50 (11): : 1473 - 1477
  • [9] A MULTICENTER, RANDOMIZED, OPEN LABEL, SINGLE- AND MULTIPLE-DOSE, DOSE FINDING STUDY AND OPEN-LABEL EXTENSION TO ASSESS THE EFFECTS OF OBETICHOLIC ACID IN PEDIATRIC PATIENTS WITH BILIARY ATRESIA
    Karpen, S.
    Eliot, L.
    Scholz, B.
    Joshi, M. M.
    Merrigan, M. M.
    Sciacca, C.
    Marmon, T.
    Hooshmand-Rad, R.
    MacConell, L.
    Shapiro, D.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S294 - S294
  • [10] A Phase 1, Open-Label, Single-Dose Study to Evaluate Pharmacokinetics of MEDI0382 in Patients with Renal Impairment
    Klein, Gernot K.
    Petrone, Marcella
    Yang, Ye
    Hoang, Thuong
    Dicostanza, Sheila
    Hansen, Lars
    Flor, Armando
    DIABETES, 2019, 68
12345